2-tert-butylhydroquinone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diomede, L; Enouf, J; Giannì, M; Launay, S; Machesky, LM; Papp, B | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR alpha and calcium-dependent signaling.
Topics: Calcium; Calcium Signaling; CD11b Antigen; Cell Differentiation; Drug Synergism; Endoplasmic Reticulum; Gene Expression Regulation, Leukemic; HL-60 Cells; Homeostasis; Humans; Hydroquinones; Indoles; Leukemia, Promyelocytic, Acute; NADPH Oxidases; Neoplasm Proteins; Oncogene Proteins, Fusion; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Thapsigargin; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 2003 |